DJIA 18,189.21 -25.21 -0.14%
NASDAQ 4,981.20 -6.69 -0.13%
S&P 500 2,111.20 0.46 0.02%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

67.94 0.61 (0.91%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ISIS $68.05 1.07%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $67.81
Previous Close $67.33
Daily Range $67.02 - $69.98
52-Week Range $22.25 - $75.24
Market Cap $8.0B
P/E Ratio -82.11
Dividend (Yield) $0.00 (0.0%)
Volume 2,176,644
Average Daily Volume 2,986,676
Current FY EPS -$0.53

Sector

Healthcare

Industry

Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary

1 George Soros Quote Every Investor Should Read Right Now

Macroeconomic and industry-specific factors have caused global stock markets to get off to a wobbly start this year. The controversial billionaire and hedge fund guru George Soros reminds us all, though, that market conditions can change in flash.

Earnings Scheduled For February 27, 2015

Pre-Market Earnings Report for February 27, 2015 : IEP, NRG, ISIS, HPT, XLS, NRF, CST, RDC, KBR, PT

Pre-Market Earnings Report for February 27, 2015 : IEP, NRG, ISIS, HPT, XLS, NRF, CST, RDC, KBR, PTCT, PNM, HZNP

iShares Russell 2000 Growth ETF Experiences Big Inflow

IWM, SSG: Big ETF Outflows

Can Isis Pharmaceuticals (ISIS) Beat Earnings this Season? - Analyst Blog

Enbridge Energy Partners Is Cheap - Cramer's Lightning Round (2/23/15)

Will Celldex Therapeutics (CLDX) Disappoint This Earnings? - Analyst Blog

Will BioMarin (BMRN) Beat Estimates this Earnings Season? - Analyst Blog

What's in Store for Endocyte (ECYT) this Earnings Season? - Analyst Blog

Will Express Scripts (ESRX) Beat Q4 Earnings Estimates? - Analyst Blog

See More ISIS News...

ISIS's Top Competitors

ISIS $67.94 (0.91%)
Current stock: ISIS
AMGN $157.62 (-0.85%)
Current stock: AMGN
GILD $103.13 (-1.02%)
Current stock: GILD
BIIB $410.40 (0.07%)
Current stock: BIIB